SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-12-000840
Filing Date
2012-02-23
Accepted
2012-02-23 14:50:55
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tdlp_10q.htm 10-Q 564217
2 CERTIFICATION tdlp_ex311.htm EX-31.1 18166
3 CERTIFICATION tdlp_ex312.htm EX-31.2 18636
4 CERTIFICATION tdlp_ex321.htm EX-32.1 8439
5 CERTIFICATION tdlp_ex322.htm EX-32.2 8226
  Complete submission text file 0001354488-12-000840.txt   1655528

Data Files

Seq Description Document Type Size
6 INS XBRL INSTANCE DOCUMENT tdlp-20110630.xml EX-101.INS 131235
7 XBRL TAXONOMY EXTENSION SCHEMA tdlp-20110630.xsd EX-101.SCH 11078
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tdlp-20110630_cal.xml EX-101.CAL 30425
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tdlp-20110630_def.xml EX-101.DEF 7086
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tdlp-20110630_lab.xml EX-101.LAB 83398
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tdlp-20110630_pre.xml EX-101.PRE 59979
Mailing Address 4225 EXECUTIVE SQUARE SUITE 485 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 485 LA JOLLA CA 92037 (858) 457-5300
TRANSDEL PHARMACEUTICALS INC (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52998 | Film No.: 12633376
SIC: 2834 Pharmaceutical Preparations